Skip to content

Clinical study to evaluate efficacy of Kamalanashakyoga in Bahupitta Kamala w.s.r to Unconjugated Jaundice

Randomised open controlled clinical study to evaluate efficacy of Kamalanashakyoga(Dantimool +Gudh)in Bahupitta Kamala w.s.r to Unconjugated Jaundice

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/09/045282
Enrollment
130
Registered
2022-09-07
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K769- Liver disease, unspecified Health Condition 2: K769- Liver disease, unspecified

Interventions

None listed

Sponsors

Dr Mamta Kadam
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subject will be included irrespective of gender,religion, economical status, Occupation education etc 2.Subject having complains of Peeta varnata, Daurbalya, Avipaka, Daha, Aruchi, Angsaad 3.Subjects in the age group of 16 to 60 years 4.Subject having serum bilirubin level more than 1 mg/dL

Exclusion criteria

Exclusion criteria: 1.pregnancy 2.kamala with updrava and Kamala occuring as an updrava in other diseases 3.Cirrhosis of liver 4.Obstructive jaundice 5.Chronic hepatitis 6.subjects having serum bilirubin level more than 10 mg /dL 7.Patients with serum bilirubin level less than 1 mg/dL

Design outcomes

Primary

MeasureTime frame
Decrease in symptoms 1.peetavarnata of netra,mutra,mala,twaka 2.Daurbalya 3.Avipak 4.Daha 5.Aruchi 6.AngasadTimepoint: 15 days

Secondary

MeasureTime frame
Decreased serum bilirubinTimepoint: 30 days

Countries

India

Contacts

Public ContactDr Mamta Kadam

Yashwant Ayurvedic Medical College and Research Center Kodoli

vasudha.borakhade@gmail.com9822885710

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026